CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 56 enrolled
Drug / intervention
Red blood cell transfusionbiological
Likely dose
Red blood cell transfusion 1 unitfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00968227
NCT00968227Phase 2Completed
CompareCT.gov

Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage

Washington University School of Medicine·interventional·Posted Aug 28, 2009·Updated Apr 17, 2017

In Brief

A Phase 2 clinical trial evaluating Red blood cell transfusion for Subarachnoid Hemorrhage and Vasospasm. Completed, enrolled 56 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if giving blood transfusions to anemic patients with subarachnoid hemorrhage will reduce their chances of having a stroke from vasospasm.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubarachnoid Hemorrhage, Vasospasm
CountriesUnited States
CollaboratorsNational Institute of Neurological Disorders and Stroke (NINDS)

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 28, 2009
Enrollment StartNov 1, 2007
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 16.8 years ago

Interventions

Red blood cell transfusionbiological

Transfusion of 1 unit of packed red blood cells over 1 hour.